Introduction:Basic information about CAS 34391-04-3|Levalbuterol, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Levalbuterol |
|---|
| CAS Number | 34391-04-3 | Molecular Weight | 239.311 |
|---|
| Density | 1.2±0.1 g/cm3 | Boiling Point | 433.5±40.0 °C at 760 mmHg |
|---|
| Molecular Formula | C13H21NO3 | Melting Point | / |
|---|
| MSDS | / | Flash Point | 159.5±17.9 °C |
|---|
Names
| Name | (R)-salbutamol |
|---|
| Synonym | More Synonyms |
|---|
Levalbuterol BiologicalActivity
| Description | Levalbuterol ((R)-Albuterol; (R)-Salbutamol) is a short-acting β2-adrenergic receptor agonist and the active (R)-enantiomer of Salbutamol. Levalbuterol is a more potent bronchodilator than Salbutamol and has the potential for the treatment of COPD[1]. |
|---|
| Related Catalog | Signaling Pathways >>GPCR/G Protein >>Adrenergic ReceptorResearch Areas >>Inflammation/Immunology |
|---|
| In Vitro | Levalbuterol (10 μM; 24 hours) induces 11β-HSD1 mRNA expression, however, it does not influence 11β-HSD2expression in airway epithelial cells[1]. Levalbuterol (10 μM; 24 hours) significantly reduces both LPS- and TNF-α-induced NF-κB activity while increasing GRE activation in an 11β-HSD1 dependent manner in a transformed mouse airway epithelial cell line[1]. RT-PCR[1] Cell Line: Murine Club (MTCC) cells Concentration: 10 μM Incubation Time: 24 hours Result: Increased 11β-HSD1 mRNA expression selectively. |
|---|
| In Vivo | Levalbuterol (subcutaneous injection; 1 mg/kg; 14 days) significantly decreases pulmonary inflammation in OVA mice, demonstrated a decrease in eosinophilia and IgE[3]. Animal Model: C57BL/6 female mice with a pulmonary allergic model[3] Dosage: 1 mg/kg Administration: Subcutaneous injection; 1 mg/kg; 14 days Result: Decreased pulmonary inflammation after OVA sensitization. |
|---|
| References | [1]. Randall MJ, et al. Anti-inflammatory effects of levalbuterol-induced 11β-hydroxysteroid dehydrogenase type 1 activity in airway epithelial cells.Front Endocrinol (Lausanne). 2015 Jan 12;5:236. [2]. Ferrada MA, et al. (R)-albuterol decreases immune responses: role of activated T cells.Respir Res. 2008 Jan 14;9:3. |
|---|
Chemical & Physical Properties
| Density | 1.2±0.1 g/cm3 |
|---|
| Boiling Point | 433.5±40.0 °C at 760 mmHg |
|---|
| Molecular Formula | C13H21NO3 |
|---|
| Molecular Weight | 239.311 |
|---|
| Flash Point | 159.5±17.9 °C |
|---|
| Exact Mass | 239.152145 |
|---|
| PSA | 72.72000 |
|---|
| LogP | 0.01 |
|---|
| Vapour Pressure | 0.0±1.1 mmHg at 25°C |
|---|
| Index of Refraction | 1.566 |
|---|
| InChIKey | NDAUXUAQIAJITI-LBPRGKRZSA-N |
|---|
| SMILES | CC(C)(C)NCC(O)c1ccc(O)c(CO)c1 |
|---|
| Storage condition | 2-8°C |
|---|
Toxicological Information
CHEMICAL IDENTIFICATION - RTECS NUMBER :
- CZ6426700
- CHEMICAL NAME :
- 1,3-Benzenedimethanol, alpha(sup 1)-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-, (-)-
- CAS REGISTRY NUMBER :
- 34391-04-3
- LAST UPDATED :
- 199606
- DATA ITEMS CITED :
- 1
- MOLECULAR FORMULA :
- C13-H21-N-O3
- MOLECULAR WEIGHT :
- 239.35
HEALTH HAZARD DATAACUTE TOXICITY DATA - TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 225 mg/kg/90D-I
- TOXIC EFFECTS :
- Endocrine - hypoglycemia Endocrine - changes in spleen weight
- REFERENCE :
- TOXID9 Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1- 1981- Volume(issue)/page/year: 30,106,1996
|
Safety Information
| Hazard Codes | Xn: Harmful; |
|---|
| Risk Phrases | R22 |
|---|
| Safety Phrases | S36 |
|---|
| HS Code | 2922509090 |
|---|
Customs
| HS Code | 2922509090 |
|---|
| Summary | 2922509090. other amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
|---|
Synonyms
| (-)-Albuterol |
| (R)-albuterol |
| R-Albuterol |
| Levosalbutamol |
| (a1R)-a1-[[(1,1-Dimethylethyl)amino]methyl]-4-hydroxy-1,3-benzenedimethanol |
| (l)-albuterol |
| (R)-a1-((tert-Butylamino)methyl)-4-hydroxy-m-xylene-a,a'-diol |
| 1,3-Benzenedimethanol, α-[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-, (αR)- |
| (-)-a1-(((1,1-Dimethylethyl)amino)methyl)-4-hydroxy-1,3-benzenedimethanol |
| (R)-salbutamol |
| 4-[(1R)-2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol |
| 2-(Hydroxymethyl)-4-{(1R)-1-hydroxy-2-[(2-methyl-2-propanyl)amino]ethyl}phenol |
| R-Salbutamol |
| UNII-EDN2NBH5SS |
| (-)-Salbutamol |
| Levalbuterol |
| Albuterol |
| MFCD00869868 |
| 1,3-Benzenedimethanol, α1-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-, (α1R)- |
| Salbutamol |